Retinol-binding protein 4 (RBP4) as the causative factor and marker of vascular injury related to insulin resistance
- PMID: 28026829
Retinol-binding protein 4 (RBP4) as the causative factor and marker of vascular injury related to insulin resistance
Abstract
One of adipokines involved in the development of insulin resistance is retinol-binding protein 4(RBP4). The physiological role of RBP4 is transport of retinol from the liver to peripheral tissues. One of the first events related to the excessive visceral fat accumulation is the development of inflammation followed by hormonal adipose tissue dysfunction, including excessive RBP4 production. Reduced density of the membrane-type glucose transporter 4 (GLUT4) is considered as a direct cause for the stimulation of RBP4 release to the circulation by adipocytes. Circulating RBP4 inhibits the signal pathways stimulated by insulin in skeletal muscle cells, resulting in the development of insulin resistance. Drugs stimulating receptor peroxisome proliferator-activated gamma (PPARγ) - thiazolidinediones - inhibit the production of RBP4 by adipose tissue and increase the insulin sensitivity of the tissues. Increased secretion of RBP4 stimulates the expression of adhesion molecules in the endothelial cells, promoting development of atherosclerosis and arterial hypertension. Population studies demonstrated an association between serum RBP4 in the circulation, and the severity of atherosclerosis and risk of the cardiovascular events and type 2 diabetes. It also appears that the rbp4 gene functional polymorphisms may influence the risk of metabolic complications of obesity, including vascular injury. Therefore, the concentration of RBP4 in the circulation may be considered both as the causative factor and marker of chronic vascular injury. This article summarizes the current state of knowledge on the potential role of RBP4 in the pathogenesis of cardiovascular diseases, particularly related to insulin resistance.
Similar articles
-
Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes.Nutr Rev. 2007 May;65(5):251-6. doi: 10.1111/j.1753-4887.2007.tb00302.x. Nutr Rev. 2007. PMID: 17566551 Review.
-
Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.J Clin Endocrinol Metab. 2007 Jul;92(7):2590-7. doi: 10.1210/jc.2006-0816. Epub 2007 Jun 26. J Clin Endocrinol Metab. 2007. PMID: 17595259 Free PMC article.
-
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.Nature. 2005 Jul 21;436(7049):356-62. doi: 10.1038/nature03711. Nature. 2005. PMID: 16034410
-
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.N Engl J Med. 2006 Jun 15;354(24):2552-63. doi: 10.1056/NEJMoa054862. N Engl J Med. 2006. PMID: 16775236
-
Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review).Mol Med Rep. 2022 Jul;26(1):244. doi: 10.3892/mmr.2022.12760. Epub 2022 Jun 3. Mol Med Rep. 2022. PMID: 35656886 Free PMC article. Review.
Cited by
-
Is the Retinol-Binding Protein 4 a Possible Risk Factor for Cardiovascular Diseases in Obesity?Int J Mol Sci. 2020 Jul 23;21(15):5229. doi: 10.3390/ijms21155229. Int J Mol Sci. 2020. PMID: 32718041 Free PMC article. Review.
-
Association Between Circulating Retinol-Binding Protein 4 and Adverse Cardiovascular Events in Stable Coronary Artery Disease.Front Cardiovasc Med. 2022 Mar 17;9:829347. doi: 10.3389/fcvm.2022.829347. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35369314 Free PMC article.
-
The Relationship between Retinol-Binding Protein 4 and Markers of Inflammation and Thrombogenesis in Children with Kawasaki Disease.Mediators Inflamm. 2021 Jan 11;2021:7029514. doi: 10.1155/2021/7029514. eCollection 2021. Mediators Inflamm. 2021. PMID: 33505217 Free PMC article.
-
Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetes.J Clin Lipidol. 2021 Jan-Feb;15(1):235-242. doi: 10.1016/j.jacl.2020.10.006. Epub 2020 Oct 31. J Clin Lipidol. 2021. PMID: 33257283 Free PMC article.
-
Elevated retinol binding protein 4 levels are associated with atherosclerosis in diabetic rats via JAK2/STAT3 signaling pathway.World J Diabetes. 2021 Apr 15;12(4):466-479. doi: 10.4239/wjd.v12.i4.466. World J Diabetes. 2021. PMID: 33889291 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous